Pharma Journalist -

SMi Group reports: ahead of the conference in February 2022, a snapshot or key speakers and presentations are released SMi Group are delighted to announce the 13th Annual Conference…
Read More...

Alcami, a leading United States-based contract development and manufacturing organization (CDMO), announced that they have signed a master laboratory services agreement with Novavax, a…
Read More...

ACELYRIN, INC., an innovative clinical-stage biopharma company that identifies, acquires, and accelerates the development and commercialization of life-changing therapies, today…
Read More...

Lonza announced it has invested in additional microbial development capabilities in Switzerland. The investment will support increased capacity of development services targeting…
Read More...

SOTIO Biotech, a clinical stage immuno-oncology company owned by PPF Group, announced an exclusive, target-specific license and option agreement with LegoChem Biosciences Inc. a…
Read More...

Kala Pharmaceuticals, Inc. a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye,…
Read More...

Arranta Bio, a leading contract development and manufacturing organization (CDMO) supporting advanced therapy pioneers, announced the completion of the sale of its process development…
Read More...

Moderna Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, confirmed that Health Canada authorized the use of a booster dose of the Moderna…
Read More...

MimiVax LLC, a clinical-stage biotechnology company in Buffalo, NY, USA, developing immunotherapeutics for cancer and autoimmune diseases, announced today that the company has received…
Read More...

Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and SK bioscience, Co. Limited (SK…
Read More...